Structure of the δ-opioid receptor bound to naltrindole

[1]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[2]  Bryan L. Roth,et al.  Structure of the human kappa opioid receptor in complex with JDTic , 2012, Nature.

[3]  A. Kruse,et al.  Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist , 2011, Nature.

[4]  R. Stevens,et al.  Structure of the human k-opioid receptor in complex with JDTic , 2012 .

[5]  K. Befort,et al.  The delta opioid receptor: an evolving target for the treatment of brain disorders. , 2011, Trends in pharmacological sciences.

[6]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[7]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[8]  Arthur Christopoulos,et al.  A Novel Mechanism of G Protein-coupled Receptor Functional Selectivity , 2008, Journal of Biological Chemistry.

[9]  Gebhard F. X. Schertler,et al.  Structure of a β1-adrenergic G-protein-coupled receptor , 2008, Nature.

[10]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[11]  B. Delateur,et al.  Restoration of Function , 2007, Journal of burn care & research : official publication of the American Burn Association.

[12]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[13]  M. Eguchi.  Recent advances in selective opioid receptor agonists and antagonists , 2004, Medicinal research reviews.

[14]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[15]  D. Ferguson,et al.  Investigation of the selectivity of oxymorphone- and naltrexone-derived ligands via site-directed mutagenesis of opioid receptors: exploring the "address" recognition locus. , 2001, Journal of medicinal chemistry.

[16]  H. Akil,et al.  Selectivity of mu-opioid receptor determined by interfacial residues near third extracellular loop. , 2000, European journal of pharmacology.

[17]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[18]  F. Monsma,et al.  Creating a functional opioid alkaloid binding site in the orphanin FQ receptor through site-directed mutagenesis. , 1998, Molecular pharmacology.

[19]  J. Dodge,et al.  Structure/activity relationships , 1998 .

[20]  C. Wahlestedt,et al.  Novel “Restoration of Function” Mutagenesis Strategy to Identify Amino Acids of the δ-Opioid Receptor Involved in Ligand Binding* , 1997, The Journal of Biological Chemistry.

[21]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[22]  C. Chen,et al.  Differential binding domains of peptide and non-peptide ligands in the cloned rat kappa opioid receptor. , 1994, The Journal of biological chemistry.

[23]  G Vassart,et al.  ORL1, a novel member of the opioid receptor family , 1994, FEBS letters.

[24]  P. Portoghese,et al.  Application of the message-address concept in the design of highly potent and selective non-peptide delta opioid receptor antagonists. , 1988, Journal of medicinal chemistry.

[25]  A. Lipkowski,et al.  Peptides as receptor selectivity modulators of opiate pharmacophores. , 1986, Journal of medicinal chemistry.

[26]  A Goldstein,et al.  Specific receptor for the opioid peptide dynorphin: structure--activity relationships. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. L. Larson,et al.  A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activities. , 1980, Journal of medicinal chemistry.

[28]  W. A. Sexton,et al.  STRUCTURE—ACTIVITY RELATIONSHIPS , 1958, The Journal of pharmacy and pharmacology.